InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Chan Gerald, Director. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 6 filings have been recorded. Activity tracked since 1 January 2022. The latest transaction was filed on 1 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Chan Gerald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
25,666 股Common StockSEC:0001193125-26-224606:0
7,961 股0Common StockSEC:0001492422-26-000012:0
6,267 股0Common StockSEC:0001127602-25-000400:0
3,341 股0Common StockSEC:0001127602-24-000114:0
3,867 股0Common StockSEC:0000899243-23-000670:0
4,230 股0Common StockSEC:0001127602-22-000727:0
6 条申报中的 6 条
About Chan Gerald
Chan Gerald is a Board Member at Apellis Pharmaceuticals, Inc. He contributes to the strategy and governance of the company, ensuring that decisions made align with shareholder interests. His expertise in the pharmaceutical sector is an asset for Apellis, fostering innovation and growth.
